Pain Wizard topical pain relief recalled for manufacturing specification violation
ARG Laboratories is recalling Pain Wizard pain relief cream due to propylene glycol used in manufacturing not meeting pharmaceutical grade specifications. The product was distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The FDA classified this as a Class II recall, which designates products that might cause adverse health consequences. Although no illnesses or injuries are reported in the source text, the manufacturing defect involving out-of-specification propylene glycol represents a risk-of-harm product where injury has not yet been documented, warranting a High severity rating.
Plain-English summary
ARG Laboratories, Inc. is recalling Pain Wizard, a topical cream for muscular and arthritic pain containing camphor 3% and menthol 3%, enriched with capsaicin and MSM. The product is sold in 4 oz (113.39g) tubes.
The FDA classified this as a Class II recall because the product was manufactured with propylene glycol that does not meet pharmaceutical specifications. The propylene glycol used is of a violative grade, resulting in the product being out of specification for its active ingredient.
The recalled product was distributed nationwide throughout the United States. The affected lot is 06023C1 with an expiration date of January 31, 2025. The product UPC is 8 63865 00019 2.
Consumers who have purchased this product should stop using it. Questions regarding this recall may be directed to ARG Laboratories at the address listed on the product: PO Box 1099, Johnstown, Colorado 80534.
The recalled product
- Product
- Pain Wizard, Natural Relief for Muscular & Arthritic Pain, (Camphor 3%, Menthol 3%), Enriched with Capsaicin, Camphor, Menthol & MSM, Tube, NET WT 4oz (113.39g), painwizard.com Made in the USA, PO Box 1099, Johnstown, CO 80534, UPC 8 63865 00019 2
- Manufacturer
- ARG Laboratories, Inc.
- Category
- Drug — Topical pain relief
- Hazard
- out-of-specification
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot
- 06023C1
- Exp 01/31/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27